TBC1D7 and hepatocellular carcinoma: To test this hypothesis, TBC1D7 siRNA knockdown and overexpression were performed in KIF2C-delepted and -overexpressed HCC cells, respectively; the efficacies were confirmed by Western blot analysis (Fig. S5A and S5B).